Memscap (FRA:MSBA) Stock Based Compensation: €0.00 Mil (TTM As of Dec. 2025)


FRA:MSBA Memscap SA FRA:MSBA
85 GF Score
Price €4.54
GF Value €4.20
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Memscap Stock Based Compensation?

Memscap FRA:MSBA -1.09% 85 Stock Based Compensation is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:MSBA with a GF Score™ of 85/100 and a GF Value™ of €4.20 (Fairly Valued). The stock has 2 warning signs investors should review.

Memscap's Stock Based Compensation for the six months ended in Dec. 2025 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Memscap Stock Based Compensation Related Terms

Memscap Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Memscap's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Memscap Stock Based Compensation Chart

Memscap Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.31 0.02 0.00

Memscap Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.00 0.00 0.00 0.00
FRA:MSBA
85GF Score
Memscap SA FRA:MSBA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Memscap Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

What does a Stock Based Compensation of €0.00 Mil mean?
Memscap (FRA:MSBA) has a Stock Based Compensation of €0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Memscap and its competitors.
Is Memscap's Stock Based Compensation too high?
Memscap's current Stock Based Compensation is €0.00 Mil. Overall, Memscap has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Memscap's Stock Based Compensation compare to AMAT and LRCX?
Memscap's Stock Based Compensation of €0.00 Mil can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Semiconductors company?
A good Stock Based Compensation depends on the Semiconductors industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Memscap and its competitors. Memscap's current Stock Based Compensation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Memscap stock overvalued right now?
Based on GuruFocus' analysis, Memscap (FRA:MSBA) is currently considered Fairly Valued. The stock's GF Value™ is €4.20, compared to a current price of €4.54 — trading 8.1% above its estimated fair value. The current Stock Based Compensation is €0.00 Mil. Memscap's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Memscap (FRA:MSBA), the current Stock Based Compensation is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Memscap (FRA:MSBA) Overvalued in 2026?

Based on GuruFocus' analysis, Memscap stock appears to be overvalued. The current stock price of €4.54 is trading 8.1% above its estimated GF Value™ of €4.20. GuruFocus considers Memscap to be Fairly Valued.

Key valuation signals for FRA:MSBA:

  • Stock Based Compensation: €0.00 Mil
  • GF Value™: €4.20 vs. price of €4.54 (8.1% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:MSBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Memscap Business Description

Other Exchanges 0NYT:UKMEMS:France
Address Parc Activillage des Fontaines, ZI Bernin, Bernin, FRA, 38190
Memscap SA is a France-based company. It is engaged in the provision of solutions based on micro-electromechanical systems (MEMS) technology. The company operates in four market segments: Aerospace, Medical / Biomedical, Mass Market / Other Applications, and Optical Communications / Adaptive Optics.
85GF Score

Get the complete analysis for FRA:MSBA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.54
Price
€4.20
GF Value